These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 14609681)
1. Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release. Santoveña A; Alvarez-Lorenzo C; Concheiro A; Llabrés M; Fariña JB Biomaterials; 2004 Feb; 25(5):925-31. PubMed ID: 14609681 [TBL] [Abstract][Full Text] [Related]
2. Structural properties of biodegradable polyesters and rheological behaviour of their dispersions and films. Santoveña A; Alvarez-Lorenzo C; Concheiro A; Llabrés M; Fariña JB J Biomater Sci Polym Ed; 2005; 16(5):629-41. PubMed ID: 16001721 [TBL] [Abstract][Full Text] [Related]
3. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide). Frank A; Kumar Rath S; Boey F; Venkatraman S Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers. Crow BB; Borneman AF; Hawkins DL; Smith GM; Nelson KD Tissue Eng; 2005; 11(7-8):1077-84. PubMed ID: 16144443 [TBL] [Abstract][Full Text] [Related]
5. Development of poly (lactic-co-glycolic acid) (PLGA) based implants using hot melt extrusion (HME) for sustained release of drugs: The impacts of PLGA's material characteristics. Yang F; Stahnke R; Lawal K; Mahnen C; Duffy P; Xu S; Durig T Int J Pharm; 2024 Sep; 663():124556. PubMed ID: 39122196 [TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. Ramchandani M; Robinson D J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903 [TBL] [Abstract][Full Text] [Related]
8. Potential applications of PLGA film-implants in modulating in vitro drugs release. Dorta MJ; Santoveña A; Llabrés M; Fariña JB Int J Pharm; 2002 Nov; 248(1-2):149-56. PubMed ID: 12429469 [TBL] [Abstract][Full Text] [Related]
9. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Rosas JE; Hernández RM; Gascón AR; Igartua M; Guzman F; Patarroyo ME; Pedraz JL Vaccine; 2001 Aug; 19(31):4445-51. PubMed ID: 11483270 [TBL] [Abstract][Full Text] [Related]
10. Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers. Son JS; Choi YA; Park EK; Kwon TY; Kim KH; Lee KB J Biomed Mater Res B Appl Biomater; 2013 Feb; 101(2):247-57. PubMed ID: 23143817 [TBL] [Abstract][Full Text] [Related]
11. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor. Desai KG; Mallery SR; Schwendeman SP Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553 [TBL] [Abstract][Full Text] [Related]
12. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states. Kranz H; Ubrich N; Maincent P; Bodmeier R J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603 [TBL] [Abstract][Full Text] [Related]
13. Degradation of poly (DL-lactic acid-co-glycolic acid) containing calcium carbonate and hydroxyapatite fillers--effect of size and shape of the fillers--. Tsunoda M Dent Mater J; 2003 Sep; 22(3):371-82. PubMed ID: 14621002 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: I. Synthesis and characterization. Wang N; Wu XS; Li C; Feng MF J Biomater Sci Polym Ed; 2000; 11(3):301-18. PubMed ID: 10841281 [TBL] [Abstract][Full Text] [Related]
15. Gamma-irradiation effects on biopharmaceutical properties of PLGA microspheres loaded with SPf66 synthetic vaccine. Igartua M; Hernández RM; Rosas JE; Patarroyo ME; Pedraz JL Eur J Pharm Biopharm; 2008 Jun; 69(2):519-26. PubMed ID: 18280123 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging. Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123 [TBL] [Abstract][Full Text] [Related]
17. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66. Carcaboso AM; Hernández RM; Igartua M; Gascón AR; Rosas JE; Patarroyo ME; Pedraz JL Int J Pharm; 2003 Jul; 260(2):273-82. PubMed ID: 12842346 [TBL] [Abstract][Full Text] [Related]
18. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Mi FL; Shyu SS; Lin YM; Wu YB; Peng CK; Tsai YH Biomaterials; 2003 Dec; 24(27):5023-36. PubMed ID: 14559016 [TBL] [Abstract][Full Text] [Related]
19. Degradation behaviour of self-reinforced 80L/20G PLGA devices in vitro. Välimaa T; Laaksovirta S Biomaterials; 2004; 25(7-8):1225-32. PubMed ID: 14643596 [TBL] [Abstract][Full Text] [Related]
20. PLGA implants: How Poloxamer/PEO addition slows down or accelerates polymer degradation and drug release. Hamoudi-Ben Yelles MC; Tran Tan V; Danede F; Willart JF; Siepmann J J Control Release; 2017 May; 253():19-29. PubMed ID: 28284831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]